Venus Remedies Limited

NSE:VENUSREM.NS

310 (INR) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12016 Q42013 Q42013 Q32013 Q12012 Q42012 Q32012 Q22012 Q1
Revenue 1,674.51,086.11,951.61,434.21,677.2951.51,556.41,1691,398.91,430.81,419.3471,243.442,025.61,298.111,113.7151,219.381,260.691,887.45782.33968.59878.94736.46860.749760.11883.88669.42798.211,526.1151,312.611,266.451,338.7361,116.241,104.111,120.34
Cost of Revenue 1,356.9818.21,456.61,130.8975.2479.4869.7703.3875.3861.71,080.027747.731,360.99793.61862.188688.52765.991,199.88448.555551.09471.03378.22673.126433.95472.23345422.43908.714694.88749.7813.477635.9620.28622.62
Gross Profit 317.6267.9495303.4702472.1686.7465.7523.6569.1339.32495.71664.61504.5251.527530.86494.7687.57333.775417.5407.91358.24187.623326.16411.65324.42375.78617.401617.73516.75525.259480.34483.83497.72
Gross Profit Ratio 0.190.2470.2540.2120.4190.4960.4410.3980.3740.3980.2390.3990.3280.3890.2260.4350.3920.3640.4270.4310.4640.4860.2180.4290.4660.4850.4710.4050.4710.4080.3920.430.4380.444
Reseach & Development Expenses 47.845.847.827.244.239.347.759.356.765.280.02946.9174.9828.383.63936.3942.0436.6343.91335.5428.2934.7848.3333.3632.3432.500000000
General & Administrative Expenses 0169.3312.7221.2294.8169.4-437.546172.10091.076000111.636000104.64300056.7250000000-399.142133.09141.9148.8
Selling & Marketing Expenses 00-1.10294.8169.4247.9172.1187.2193.8-76.926192.24191.6180.18-87.825193.6227.31327.21-5.558158.17147.77117.23-35.594145.69112.9591.0200000000
SG&A 284.6169.3311.6221.2294.8169.4247.9172.1187.2193.814.15192.24191.6180.1823.811193.6227.31327.2199.085158.17147.77117.2321.131145.69112.9591.0266.1000-109.765133.09141.9148.8
Other Expenses 015.939.223.530.522.632.838.117.914.4-49.82512.1628.919.54-31.24918.27122.7620.35-15.68517.7313.458.23-23.1898.631.325.890378.897356.148.18417.61124.87131.12128.15
Operating Expenses 332.4215.1359.4248.4588.5443.6523.5456.9483.8502359.506457.77478.65422.43300.378437.01474.31567.95323.151394.33366.48345.4256.829361.87335.62310.08287.54378.897356.14296.03307.845257.96273.02276.95
Operating Income -14.852.8135.65514428.519646.957.767.1-76.161126.04214.8682.07-48.85193.8520.39119.6210.62423.1741.4312.84-69.206-35.7176.0314.3488.24199.38178.16220.72217.414222.38210.81220.77
Operating Income Ratio -0.0090.0490.0690.0380.0860.030.1260.040.0410.047-0.0540.1010.1060.063-0.0440.0770.0160.0630.0140.0240.0470.017-0.08-0.0470.0860.0210.1110.1310.1360.1740.1620.1990.1910.197
Total Other Income Expenses Net 105.515.73922.8-0.6221.3-1.517.911.878.472-3.12-0.2718.13230.83544.79124.77-99.89-56.289-22.93-35.63-53.57-46.472-87.13-76.82-72.29-80.03-39.123-83.43-58.63-60.204-52.94-53.72-76.15
Income Before Tax 90.768.5174.677.8143.450.5197.345.457.778.92.31146.98214.59100.2181.984138.64145.1619.73-45.6650.245.8-40.73-115.678-122.84-0.79-57.958.21199.381178.16162.09157.21169.44157.09144.62
Income Before Tax Ratio 0.0540.0630.0890.0540.0850.0530.1270.0390.0410.0550.0020.0380.1060.0770.1630.1140.1150.01-0.05800.007-0.055-0.134-0.162-0.001-0.0870.010.1310.1360.1280.1170.1520.1420.129
Income Tax Expense 55.656.369.69.34438.786.712.54.410-0.021-9.48-16.89-16.77-169.1122.0914.920.358.1499.851.648.23-1.02-5.54-4.935.8937.0424.8225.888.9736.0388.896.174.17
Net Income 35.112.2105.268.599.411.8110.55832.953.368.92.33256.5231.5117351.094116.55130.2619.73-53.803-9.624.16-40.73-114.647-117.34.14-57.9545.25174.558172.28153.12121.173160.55150.92140.45
Net Income Ratio 0.0210.0110.0540.0480.0590.0120.0710.0280.0380.0480.0020.0450.1140.090.3150.0960.1030.01-0.069-0.010.005-0.055-0.133-0.1540.005-0.0870.0570.1140.1310.1210.0910.1440.1370.125
EPS 2.630.917.865.127.440.888.272.463.995.160.184.2217.328.8628.449.4410.551.6-4.37-0.780.34-3.3-9.3-9.50.34-4.73.9414.1415.0653.539.6816.4815.4914.42
EPS Diluted 2.630.917.865.127.440.888.272.463.995.160.184.2217.328.8628.449.4410.551.6-4.36-0.780.34-3.3-9.29-9.50.34-4.73.9414.1415.0653.539.6816.4815.4914.42
EBITDA 155112.6194.7120.4208.4126.6278.9119.1147.6159.575.109136.53301.94187.8419.788199.09229.24225.86140.867125.67140.52106.06-2.29857.94192.72104.94176.681342.783358.76316.07283.901302.47290.58298.46
EBITDA Ratio 0.0930.1040.10.0840.1240.1330.1790.1020.1060.1110.0530.110.1490.1450.0180.1630.1820.120.180.130.160.144-0.0030.0760.2180.1570.2210.2250.2730.250.2120.2710.2630.266